Company intelligence / Profile preview

CLC Scientific

Aarhus, Denmark

Ownership: Private
Employees: ~100
Development stage: Other

Overview

CLC bio (frequently cited as CLC Scientific) was a premier bioinformatics company specializing in high-performance computing and software for biological data analysis. The company is best known for its CLC Genomics Workbench, a comprehensive platform that provides researchers with user-friendly tools for next-generation sequencing (NGS) data analysis, including de novo assembly, read mapping, and variant detection. In 2013, CLC bio was acquired by QIAGEN to bolster its "Sample to Insight" workflow, integrating the software into QIAGEN's bioinformatics suite. Today, the technology remains a core component of the QIAGEN Digital Insights portfolio, serving thousands of academic, clinical, and industrial laboratories worldwide.

Industry: Biomedical IT and Biomedical Data Platforms

Partnerships

IntelIBMBio-Rad

Beyond the preview

Go deeper on CLC Scientific.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on CLC Scientific.

Explore the full profile